HK1157225A1 - Compositions and methods for skin care - Google Patents

Compositions and methods for skin care

Info

Publication number
HK1157225A1
HK1157225A1 HK11111723.8A HK11111723A HK1157225A1 HK 1157225 A1 HK1157225 A1 HK 1157225A1 HK 11111723 A HK11111723 A HK 11111723A HK 1157225 A1 HK1157225 A1 HK 1157225A1
Authority
HK
Hong Kong
Prior art keywords
compositions
methods
skin
skin care
antioxidant compound
Prior art date
Application number
HK11111723.8A
Other languages
English (en)
Inventor
Michael Patrick Murphy
Robin A J Smith
Kenneth Martin Taylor
Original Assignee
Antipodean Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antipodean Pharmaceuticals Inc filed Critical Antipodean Pharmaceuticals Inc
Publication of HK1157225A1 publication Critical patent/HK1157225A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
HK11111723.8A 2008-04-01 2011-10-31 Compositions and methods for skin care HK1157225A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4155108P 2008-04-01 2008-04-01
PCT/US2009/038123 WO2009145982A1 (en) 2008-04-01 2009-03-24 Compositions and methods for skin care

Publications (1)

Publication Number Publication Date
HK1157225A1 true HK1157225A1 (en) 2012-06-29

Family

ID=41164501

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11111723.8A HK1157225A1 (en) 2008-04-01 2011-10-31 Compositions and methods for skin care

Country Status (17)

Country Link
US (3) US20090258841A1 (ko)
EP (1) EP2271349B1 (ko)
JP (3) JP6227856B2 (ko)
KR (2) KR101715631B1 (ko)
CN (1) CN102046178B (ko)
AU (1) AU2009251711B2 (ko)
BR (1) BRPI0910874B8 (ko)
CA (1) CA2719658C (ko)
ES (1) ES2628407T3 (ko)
HK (1) HK1157225A1 (ko)
IL (1) IL208458A (ko)
MX (1) MX2010010713A (ko)
NZ (1) NZ588806A (ko)
RU (1) RU2517594C2 (ko)
SG (2) SG189714A1 (ko)
WO (1) WO2009145982A1 (ko)
ZA (1) ZA201006941B (ko)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888334B2 (en) 2003-08-22 2011-02-15 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
NZ546070A (en) 2003-08-22 2010-01-29 Antipodean Pharmaceuticals Inc Mitoquinone derivatives used as mitochondrially targeted antioxidants
US9999635B2 (en) 2007-01-16 2018-06-19 Realm Therapeutics, Inc. Methods and compositions for treating inflammatory disorders
CA2719658C (en) * 2008-04-01 2019-10-01 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care
JP5722782B2 (ja) 2008-09-26 2015-05-27 ナノバイオ コーポレーション ナノエマルジョン治療用組成物及びその使用方法
DE102008061340A1 (de) * 2008-12-11 2010-09-23 Henkel Ag & Co. Kgaa Antioxidative Zusammensetzungen
US8192429B2 (en) 2010-06-29 2012-06-05 Theravant, Inc. Abnormality eradication through resonance
WO2012040342A2 (en) * 2010-09-21 2012-03-29 Conrex Pharmaceutical Corporation Restoration of hair
US9345720B2 (en) * 2010-10-26 2016-05-24 Exeltis Usa Dermatology, Inc. Composition and method for treating wounds
US9034926B2 (en) * 2010-12-30 2015-05-19 Nicholas V. Perricone Topical nitrone spin trap compositions for psoriasis
US20120207838A1 (en) * 2011-02-10 2012-08-16 Perricone Nicholas V Treatment of Psoriasis Using Oral Dosage Forms of Nitrone Spin Traps
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
KR20190089098A (ko) * 2011-04-06 2019-07-29 마리 케이 인코포레이티드 식물 추출물을 포함하는 국소 스킨 케어 제형
CA2834342C (en) 2011-04-26 2021-08-31 Retrotope, Inc. Impaired energy processing disorders and mitochondrial deficiency
CA2834343C (en) 2011-04-26 2021-10-12 Retrotope, Inc. Disorders implicating pufa oxidation
JP6106158B2 (ja) 2011-04-26 2017-03-29 レトロトップ、 インコーポレイテッドＲｅｔｒｏｔｏｐｅ， Ｉｎｃ． 酸化的網膜疾患
WO2012148926A2 (en) 2011-04-26 2012-11-01 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating pufas
US20140221320A1 (en) * 2011-07-08 2014-08-07 The Research Foundation For The State University Of New York Topical minocycline ointment for suppression of allergic skin responses
US8652531B2 (en) 2011-07-29 2014-02-18 Kimberly-Clark Worldwide, Inc. Indicator for oxygen generation
US9181093B2 (en) 2011-07-29 2015-11-10 Avent, Inc. Two part oxygen generating system
GB2493955A (en) * 2011-08-25 2013-02-27 Hds Ltd Methods and compositions for reducing allergic reactions to fragranced products and perfumes
CN103143054A (zh) * 2011-12-06 2013-06-12 贵州金玖生物技术有限公司 一种消炎、促进伤口愈合的胶体敷料
CN103446261B (zh) * 2012-06-05 2015-04-15 中国医学科学院肿瘤医院 一种预防和/或治疗肿瘤治疗相关皮肤损害的中药组合物
WO2014059008A1 (en) * 2012-10-09 2014-04-17 The Procter & Gamble Company Method of identifying or evaluating beneficial actives and compositions containing the same
JP6189962B2 (ja) 2012-10-09 2017-08-30 ザ プロクター アンド ギャンブル カンパニー 相乗作用する美容成分の組み合わせを特定する方法
US20180200320A1 (en) * 2012-11-21 2018-07-19 Aviratek Biomedical Solutions, Llc Method and compositions for the use of botanical extracts in the treatment of viral infections, cancer, pain, itch, and inflammation
US10117823B2 (en) * 2013-03-12 2018-11-06 Primal Therapies, Inc. Dental composition comprising chelator and base
JP2014172888A (ja) * 2013-03-12 2014-09-22 Kose Corp カラコギカエデ抽出物を含む細胞内酸化ストレス抑制剤
US20140314778A1 (en) 2013-03-13 2014-10-23 Genentech, Inc. Formulations with reduced oxidation
US10653779B2 (en) 2013-03-13 2020-05-19 Genentech, Inc. Formulations with reduced oxidation
SG10201705525VA (en) * 2013-03-13 2017-08-30 Genentech Inc Formulations with reduced oxidation
JP2015051934A (ja) * 2013-09-05 2015-03-19 地方独立行政法人青森県産業技術センター 皮膚の酸化的ストレス抑制剤
JP6497690B2 (ja) * 2013-09-26 2019-04-10 地方独立行政法人青森県産業技術センター マトリックスメタロプロテアーゼ−１産生抑制剤
EP3114110A1 (en) * 2014-03-07 2017-01-11 Dow Global Technologies LLC Nitrone compounds and their use in personal care
ES2889874T3 (es) 2014-03-13 2022-01-14 Retrotope Inc Tratamiento de neuropatía óptica y reducción del estrés oxidativo inducido por esteroides con sustancias polinsaturadas estabilizadas
WO2015138819A1 (en) 2014-03-14 2015-09-17 Livepet, Llc. Cellular enhancements through lipofullerene and peptide group combinations
JP2017515814A (ja) * 2014-05-12 2017-06-15 ダウ グローバル テクノロジーズ エルエルシー ニトロン化合物及びパーソナルケアにおけるその使用
CN106794158A (zh) * 2014-05-30 2017-05-31 劳伦斯·T·弗里霍夫 具有多重抗药性抑制性质的抗微生物药物组合物
CN104173212B (zh) * 2014-09-10 2016-08-17 百莲凯国际企业管理（北京）有限公司 一种再生霜及其制备工艺
WO2016046726A1 (en) * 2014-09-23 2016-03-31 Anjon Biologics, Inc. Mineral based compositions and use thereof
CN107206019B (zh) * 2014-12-16 2021-09-24 优格美国有限公司 用于治疗皮肤病症的次氯酸制剂和方法
US10617716B2 (en) 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions
CN104771332B (zh) * 2015-03-16 2018-03-16 珠海市雅莎医疗器械有限公司 一种改善油脂分泌的羽毛质感乳液
KR101773404B1 (ko) 2015-08-25 2017-08-31 (주) 씨유스킨 자외선에 의한 피부 손상의 예방 또는 개선을 위한 화장료 조성물
KR102591220B1 (ko) * 2015-09-04 2023-10-18 폴리 엠디 에스.알.엘. 인유두종 바이러스 피부 감염의 치료를 위한 아세틸살리실산을 포함하는 조성물 및 의료 장치
JP2018527401A (ja) * 2015-09-17 2018-09-20 ジューン ジェイコブス ラボラトリーズ， エルエルシー 放射線皮膚炎の処置および予防のための組成物および方法
CN105106108B (zh) * 2015-09-28 2018-06-01 薇碧生物科技（上海）有限公司 超分子控缓释型水杨酸配方及其制备技术
CN105147596B (zh) * 2015-09-28 2018-06-01 薇碧生物科技（上海）有限公司 水溶性超分子水杨酸凝胶技术
KR20180081602A (ko) * 2015-11-18 2018-07-16 사이버그 컨설팅, 엘엘씨 천연 추출물을 함유하는 조성물 및 피부 및 모발을 위한 그의 용도
CN105748733A (zh) * 2016-03-14 2016-07-13 广东岭南职业技术学院 四叶草湿疹止痒膏及其制备方法
WO2018075810A1 (en) * 2016-10-18 2018-04-26 Somahultion, Llc Dermatological compositions for providing nutrients to skin and methods thereof
CN110167546A (zh) 2016-11-17 2019-08-23 乐巢拓普有限公司 同位素修饰的组分及其治疗用途
US10293054B2 (en) 2017-02-23 2019-05-21 LivePet, LLC Lipofullerene-saccharide conjugates and their use as antimetastatic agents for the inhibition of mammalian neoplasms
KR102113754B1 (ko) * 2017-07-07 2020-05-20 주식회사 리포바이오메드 화상 및 욕창의 완화 및 치료용 조성물
EP3459589A1 (en) * 2017-09-20 2019-03-27 L'oreal Iontophoresis method of delivering vitamin c through the skin
RU2674981C1 (ru) * 2017-11-29 2018-12-14 Ольга Валерьевна Самодай Способ лечения угревой болезни
WO2019113210A1 (en) * 2017-12-05 2019-06-13 Anthos Partners, Lp Phosphonium-based ionic drug conjugates
CN107951804A (zh) * 2017-12-14 2018-04-24 柳州市柳科科技有限公司 一种生姜护手霜及其制备方法
CN107823070A (zh) * 2017-12-14 2018-03-23 柳州市柳科科技有限公司 一种护手霜及其制作方法
CN108143644A (zh) * 2018-03-08 2018-06-12 广州市韵丽生物科技有限公司 一种用于护肤品内原料的制备方法
CN108619554A (zh) * 2018-06-01 2018-10-09 合肥昂诺新材料有限公司 一种促进皮肤表皮伤口愈合的愈伤介质
CN109172387B (zh) * 2018-10-24 2021-12-24 云南贝泰妮生物科技集团股份有限公司 一种改善雾化效果的喷雾制剂及其制备方法
RU2678307C1 (ru) * 2018-11-13 2019-01-25 Индивидуальный предприниматель Талагаева Елена Владимировна Активная против акне добавка к парфюмерно-косметическим продуктам
US20200197274A1 (en) * 2018-12-21 2020-06-25 L'oréal Anhydrous makeup removing composition
RU2749369C2 (ru) * 2019-04-30 2021-06-09 Общество с ограниченной ответственностью "ПРОФИТ ФАРМ" Способ лечения обширных поверхностных повреждений кожи
US11311494B2 (en) * 2019-05-13 2022-04-26 Adam Mark Murday Cold sore treatment formulation and related method of application-liquid patch for treatment of viral lesions
US11253443B2 (en) 2020-01-22 2022-02-22 Max C. Champie Skin products with C60 and niacin
KR102374634B1 (ko) 2020-01-30 2022-03-16 김영미 피부 유사 또는 투과 인지질 기술이 적용된 알파리포산 및 항산화제를 포함하는 항노화용 조성물
US20230000736A1 (en) * 2020-02-21 2023-01-05 Anjon Biologics, Inc. Compositions for skincare and use thereof
CN113712842B (zh) * 2020-05-25 2023-06-13 基元美业生物科技(上海)有限公司 一种组合物及其在制备化妆品及医疗器械中的应用
CN112280765B (zh) * 2020-09-27 2021-10-08 扬州大学 磺基甜菜碱表面活性剂在提高菠萝蛋白酶活性中的应用
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS
CN113827509B (zh) * 2021-10-22 2023-07-04 广东润和生物科技有限公司 一种辅酶q10眼霜及其制备方法
CN113876685B (zh) * 2021-11-11 2023-09-01 上海蜂花日用品有限公司 一种泡沫细腻清爽保湿的沐浴露

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
GB1466062A (en) 1974-04-09 1977-03-02 Knight K Cosmetic preparations
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US4568343A (en) 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions
US4783450A (en) 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
JPH02157287A (ja) * 1988-12-07 1990-06-18 Kanebo Ltd ベンジルトリフェニルホスホニウム塩誘導体
DE4221268C2 (de) 1992-06-26 1997-06-12 Lancaster Group Ag Verwendung eines Dermatikums zur Unterstützung des Sauerstofftransportes in der Haut
DE4221255C2 (de) 1992-06-26 1994-09-15 Lancaster Group Ag Phospholipide enthaltendes Kosmetikum
US5618850A (en) * 1995-03-09 1997-04-08 Focal, Inc. Hydroxy-acid cosmetics
CA2244535A1 (en) * 1995-05-15 2000-01-30 Avon Products, Inc. Novel uses for ascorbyl-phosphoryl-cholesterol in topical compositions
KR100195291B1 (ko) * 1997-07-12 1999-06-15 서경배 비이온성 비타민
DK1047701T3 (da) 1997-11-25 2005-08-15 Antipodean Biotechnology Ltd Antioxidanter målrettet mod mitokondrier
CA2315679A1 (en) 1997-12-24 1999-07-08 Senju Pharmaceutical Co., Ltd. Vitamin e derivatives
DE69920497T2 (de) * 1998-10-26 2006-02-09 The Research Foundation Of State University Of New York Liponsaürederivate und deren verwendung bei der behandlung von krankheiten
US20060229278A1 (en) 1998-11-25 2006-10-12 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
US6140067A (en) 1999-04-30 2000-10-31 Mitokor Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus
DE19932197A1 (de) 1999-07-09 2001-01-18 Neudecker Birgit Topisch anzuwendendes Mittel mit schützender und regenerativer Wirkung
US20020044913A1 (en) * 2000-02-11 2002-04-18 Hamilton Nathan D. Cosmetics to support skin metabolism
MY127741A (en) 2000-04-03 2006-12-29 Colgate Palmolive Co Wash-off vitamin e compositions
DE10035513A1 (de) * 2000-07-21 2002-01-31 Beiersdorf Ag Wirkstoffkombinationen bzw. Addukte aus Cyclodextrinen und mindestens einem Chinon und/oder mindestens einem Hydrochinon und Verwendung solcher Wirkstoffkombinationen in kosmetischen Zubereitungen
JP2002128651A (ja) * 2000-10-25 2002-05-09 Kose Corp 光老化抑制剤およびそれを含有することを特徴とする皮膚外用剤
WO2002076935A1 (fr) 2001-03-19 2002-10-03 Senju Pharmaceutical Co., Ltd. Nouveau derive de l'acide lipoique et son utilisation
SE0102380D0 (sv) * 2001-07-02 2001-07-02 Macronova Ab Kräm för behandling av åldersförändringar i huden hos människa
US20030059450A1 (en) 2001-09-24 2003-03-27 Maibach Howard I. Method and topical formulation for treating skin conditions associated with aging
US6984636B2 (en) * 2002-08-12 2006-01-10 Medical Research Council Mitochondrially targeted antioxidants
JP2006511585A (ja) * 2002-12-23 2006-04-06 グレイストーン メディカル グループ、インコーポレイテッド 慢性創傷管理における活性酸素種の減少
AU2004266988B2 (en) 2003-08-22 2011-05-26 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
US7888334B2 (en) * 2003-08-22 2011-02-15 Antipodean Pharmaceuticals, Inc. Mitoquinone derivatives used as mitochondrially targeted antioxidants
NZ546070A (en) * 2003-08-22 2010-01-29 Antipodean Pharmaceuticals Inc Mitoquinone derivatives used as mitochondrially targeted antioxidants
US7470798B2 (en) 2003-09-19 2008-12-30 Edison Pharmaceuticals, Inc. 7,8-bicycloalkyl-chroman derivatives
EP1830784A4 (en) 2004-12-13 2008-12-31 Aquaphotonics Inc PROCESS AND COMPOSITION AGAINST AGING
JP2008540643A (ja) * 2005-05-17 2008-11-20 三井農林株式会社 皮膚の光老化を軽減するための組成物および方法
RU2318500C2 (ru) 2005-10-18 2008-03-10 Общество С Ограниченной Ответственностью "Митотехнология" Способ воздействия на организм путем адресной доставки биологически активных веществ в митохондрии, фармацевтическая композиция для его осуществления и соединение, применяемое для этой цели
US9427444B2 (en) * 2007-01-29 2016-08-30 Mitotech Sa Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages
CA2719658C (en) * 2008-04-01 2019-10-01 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care

Also Published As

Publication number Publication date
EP2271349A1 (en) 2011-01-12
US10085966B2 (en) 2018-10-02
CN102046178A (zh) 2011-05-04
WO2009145982A1 (en) 2009-12-03
CN102046178B (zh) 2013-05-08
US20190008825A1 (en) 2019-01-10
KR20160121610A (ko) 2016-10-19
RU2517594C2 (ru) 2014-05-27
AU2009251711B2 (en) 2014-07-17
US20170340603A1 (en) 2017-11-30
KR101715631B1 (ko) 2017-03-13
ES2628407T3 (es) 2017-08-02
CA2719658C (en) 2019-10-01
IL208458A (en) 2016-08-31
KR20110015531A (ko) 2011-02-16
RU2010143806A (ru) 2012-05-10
JP2011516483A (ja) 2011-05-26
MX2010010713A (es) 2011-02-21
JP2017226685A (ja) 2017-12-28
BRPI0910874B8 (pt) 2021-05-25
CA2719658A1 (en) 2009-12-03
SG10201608068SA (en) 2016-11-29
EP2271349A4 (en) 2011-05-04
JP2016028050A (ja) 2016-02-25
SG189714A1 (en) 2013-05-31
EP2271349B1 (en) 2017-03-15
JP6227856B2 (ja) 2017-11-08
US20090258841A1 (en) 2009-10-15
AU2009251711A1 (en) 2009-12-03
IL208458A0 (en) 2010-12-30
BRPI0910874B1 (pt) 2019-10-01
BRPI0910874A8 (pt) 2018-05-15
BRPI0910874A2 (pt) 2015-10-06
NZ588806A (en) 2013-01-25
ZA201006941B (en) 2015-05-27

Similar Documents

Publication Publication Date Title
HK1157225A1 (en) Compositions and methods for skin care
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
WO2010027792A8 (en) Treatment of sweating and hyperhidrosis
MX2010004877A (es) Composiciones cosmeticas de pasos multiples.
MX358857B (es) Composiciones para el cuidado de la piel que contienen combinaciones de ingredientes naturales.
EP2568956A4 (en) COMPOSITIONS CONTAINING DNA REPAIR ENZYME AND ANOGEISSUS EXTRACT
MX2013005995A (es) Composicion topica que promueve la melanina.
MX2013001227A (es) Compuestos y metodos para reparacion de piel.
WO2012050745A3 (en) Compositions containing zinc pca and anogeissus extract
EP2671891A3 (en) Ang-2 inhibition to treat multiple sclerosis
WO2012074235A3 (ko) 피부 미백 및 탄력 개선용 화장료 조성물
UA99101C2 (ru) Композиция для местного ухода за кожей, содержащая соединения глицерина ди- и моносалицилата
MX2009005066A (es) Composiciones para mejorar la condicion y apariencia de la piel y metodos para su uso.
WO2012099449A3 (ko) 플라본계 화합물의 신규한 용도
DK2714888T3 (da) Rekombinant gær
WO2008070859A3 (en) Treatment of skin conditions by dickkopf1 (dkk1)
WO2013096736A3 (en) Compositions and methods for treating skin
MY161607A (en) Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions
SG190947A1 (en) Compounds and methods for skin repair
WO2012116990A3 (en) Novel use
HK1161090A1 (en) Topical compositions containing melicope hayesii and a method of treating skin
WO2010097788A3 (en) Visfatin therapeutic agents for the treatment of acne and other conditions
MX348531B (es) Dispositivo de lata de aerosol para suministro tópico dual.
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
WO2010098596A2 (ko) 송진 추출물, 적송엽 추출물 및 적송근 추출물을 함유하는 피부 보습용 화장료 조성물